Tuesday, 02 January 2024 12:17 GMT

Oxidative Stress Assays Market Size To Hit Us$ 2.49 Billion By 2033 X Herald


(MENAFN- Ameliorate Digital Consultancy) The global oxidative stress assays market is valued at US$ 1.05 billion in 2023 and is predicted to reachD 2.49 billion by 2033, as per a new industry analysis by Fact.MR, a market research and competitive intelligence provider.

Oxidative stress happens when a cell or organism produces an excessive amount of oxygen-derived free radicals, which overwhelms the natural antioxidant defences of the organism. Proteins, lipids, and nucleic acids suffer oxidative damage as a result, which can accelerate the development of cancer as well as cardiovascular and neurological conditions, ischemia, diabetes, and asthma. These assays aid in identifying oxidative stress.

Download Sample Copy of This Report:

Rapid development of the pharmaceutical and biotechnology sectors is a key factor fuelling the growth of the global oxidative stress assays market.

  • BioProcess International estimates that the global sales of biopharmaceuticals were valued at US$ 300 million in 2021 and are growing at a rate of 12% annually. Also, over the next ten years, it is anticipated that the global pharma market will grow at a phenomenal rate.

Recently, it has been observed that biotech companies' interest in cell concepts is increasing. High-content screening improvements are being offered by several market players. Growing R&D spending plans on healthcare are creating new paths for advancements in medical science. Furthermore, the increasing interest in chronic inflammatory mechanisms among lab researchers is expected to boost sales growth.

Key Takeaways from Market Study

  • The global oxidative stress assays market is expected to increase rapidly at a CAGR of 9% from 2023 to 2033.
  • Japan's market is predicted to expand at a CAGR of 8% during the forecast period.
  • Demand for consumables is predicted to surge at a CAGR of 9.5% during the forecast period.
  • Sales of oxidative stress assays in Germany are predicted to rise at a CAGR of 6.5% from 2023 to 2033.

Key Companies Profiled

  • Abcam PLC
  • AMS Biotechnology (Europe) Ltd. (AMSBIO)
  • Biovision Inc.
  • Cell Biolabs, Inc.
  • Enzo Biochem, Inc.
  • Merck KgaA
  • MilliporeSigma
  • Oxford Biomedical Research, Inc.
  • Promega Corporation
  • Qiagen NV
  • Thermo Fisher Scientific, Inc

Competitive Landscape

Key players in the oxidative stress assays market are focusing on the advancement of assay products. To maintain their market position and earn more, some of the leading companies are concentrating on regional expansion, local supply, changes in pricing trends, product standards, and more.

  • In July 2021, Immuchrom GmbH and Ilex Life Sciences inked a collaboration agreement for the commercialization of gastrointestinal biomarker assays in North America. Immuchrom is a German researcher and manufacturer of photometric assays, immunoassays, and HPLC applications with a foon oxidative stress, gastrointestinal disease, cardiovascular disease, and calcium and bone metabolism.
  • The Photo-oxidation Resistant DCFH-DA ROS Assay Kit was introduced in June 2022 by Dojindo, in Japan.
  • FusionPlex Dx and LiquidPlex Dx were launched by Inviin February 2022 in Europe. FusionPlex Dx is designed to be utilized as a CDx to help identify patients with NSCLC who have ROS proto-oncogene 1 (ROS1) fusions and other conditions that might improve from targeted therapy.

Key Segments of Oxidative Stress Assays Industry Research

By Offering :

  • Consumables
  • Instruments
  • Services
  • By Test Type :
    • Antioxidant Capacity Assays
    • Ascorbic Acid Assays
    • Glutathione Assays
    • Cell-based ExogenAntioxidant Assays
    • Indirect Assays
    • Lipid-based Assays
    • Nucleic Acid-based Assays
    • Protein-based Assays
    • Enzyme-based Assays
    • Reactive Oxygen Species-based Assays
  • By Technology :
    • EL
    • Chromatography
    • Flow Cytometry
    • Microscopy,
    • High-content Screening
    • Label-free Detection
  • By Disease :
    • Cardiovascular Diseases
    • Diabetes
    • Respiratory Diseases
    • Cancer
    • Asthma
  • By End User :
    • Pharma & Biotech Companies
    • Academic Research Institutes
    • Clinical Laboratories
    • Contract Research Organizations
  • By Region:
    • North America
    • Latin America
    • Europe
    • East Asia
    • South Asia & Oceania
    • MEA

Quick Buy: Oxidative Stress Assays Market Report:

Contact:
Sales Office :
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail:

MENAFN29082023004660010643ID1106978412


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Search